FDA approves new blood test for Alzheimer’s disease

Can Blood Tests Detect Alzheimer’s Disease in Its Early Stages?

By Noah Fromson Alzheimer’s disease affects more than 7 million Americans, and that number is expected to nearly double by 2060. Despite the growing number of cases, many people with Alzheimer’s disease and related dementias remain undiagnosed or untreated. Diagnosing Alzheimer’s disease can be challenging, particularly in its early stages. Brain PET scans and spinal taps (lumbar punctures) remain the gold standard for detecting the biological m…

'A huge benefit': FDA approves blood test for early Alzheimer's detection

The FDA has approved a blood test developed by Roche to detect Alzheimer's disease in adults 55 and older experiencing cognitive loss, offering a less invasive diagnostic option.

FDA approves blood test to help detect Alzheimer’s disease in people 55 and older

The test measures p-tau217, a biomarker linked to Alzheimer’s, and can return positive, intermediate or negative results to aid clinical evaluation.

FDA Clears Roche Blood Test That Can Rule Alzheimer's Amyloid In or Out Without a Brain Scan

FDA cleared Roche's Elecsys pTau217 blood test for adults 55 and older with cognitive symptoms. What it can and cannot tell patients.

FDA Clears Roche Blood Test to Help Evaluate Alzheimer’s in Adults 55 and Older

A newly cleared blood test that measures the Alzheimer’s-associated biomarker pTau217 will give primary care physicians and specialists another less-invasive tool for evaluating patients experiencing ... The post FDA Clears Roche Blood Test to Help Evaluate Alzheimer’s in Adults 55 and Older first appeared on [your]NEWS.